Literature DB >> 12860280

Integrin receptors and ECM proteins involved in preferential adhesion of colon carcinoma cells to lung cells.

Sougata Karmakar1, Rama Mukherjee.   

Abstract

To assess the putative role of extracellular matrix (ECM) proteins on lung cells interacting with integrin receptors on colon carcinoma cells, an in vitro adhesion assay was used to investigate these factors. Tumor necrosis factor (TNF)-alpha treatment of fetal lung cell line MRC 9, upregulated expression of ECM proteins and also supported enhanced adhesion of PTC colon carcinoma cells. Antibodies to ECM proteins significantly blocked this enhanced adhesion of PTC cells. Similarly, antibody blocking of beta1 and beta2 integrin receptors on PTC cells revealed the integrin receptors involved in this enhanced adhesion. beta1 integrin receptors like alpha2beta1, alpha4beta1 and alpha5beta1 on PTC cells were found interacting with their ECM ligands like fibronectin and laminin on TNF-alpha stimulated MRC 9 cells. Interestingly, PTC cells were found to constitutively express alphaLbeta2, which is normally expressed by leukocytes. The data from the present study indicates that expression of multiple beta1 and beta2 integrins by colon carcinoma cells putatively allows these cells to successfully adhere to secondary sites like lungs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860280     DOI: 10.1016/s0304-3835(03)00208-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

1.  The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.

Authors:  Kazunori Hata; Junji Yoshida; Hibiki Udagawa; Hiroko Hashimoto; Satoshi Fujii; Tomoyuki Hishida; Takeshi Kuwata; Keiju Aokage; Motohiro Kojima; Atsushi Ochiai; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-08       Impact factor: 4.553

2.  Adhesion of different cell cycle human hepatoma cells to endothelial cells and roles of integrin beta1.

Authors:  Guan-Bin Song; Jian Qin; Qing Luo; Xiao-Dong Shen; Run-Bin Yan; Shao-Xi Cai
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer.

Authors:  P Bohanes; D Yang; F Loupakis; M J LaBonte; A Gerger; Y Ning; C Lenz; F Lenz; T Wakatsuki; W Zhang; L Benhaim; A El-Khoueiry; R El-Khoueiry; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2014-12-09       Impact factor: 3.550

4.  Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.

Authors:  Marcelo Moura Linhares; Renato José Affonso; Luciano de Souza Viana; Sandra Regina Morini Silva; Marcos Vinicius Araujo Denadai; Silvia Regina Caminada de Toledo; Delcio Matos
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.